Characteristics:
| Type |
Drops |
| Purpose |
Antiparasitic |
| Packaging |
3 pieces
|
| Manufacturer |
Boeringer, France |
Description:
NextGuard Combo x 3
Nexgard Combo topical solution for cats < 2.5 kg
Esafoxolaner, Eprinomectin, Praziquantel
Description:
| Nexgard Combo |
Unit dose volume (ml) |
Esafoxolaner (mg) |
Eprinomectin (mg) |
Praziquantel(mg)
|
| Cats < 2.5 kg |
0.9 |
10.80 |
3.60 |
74.70 |
Excipients:
Butylhydroxytoluene (E32l) 1 mg/ml.
Solution for on-site use.
A clear, colorless light yellow to light brown solution.
testimonials
For cats with or at risk of mixed infections with cestodes, nematodes and ectoparasites. Veterinary medicine is indicated when all three groups are targeted simultaneously.
Ectoparasites
- Treatment of flea infestations
(Ctenocephalides felis). One treatment provides immediate and continuous flea control for one month.
The product can be used as part of a treatment strategy to control flea-induced allergic dermatitis (FAD).
- Treatment of tick infestations. A single treatment provides immediate and sustained tick control for one month against Ixodes scapularis and five weeks against Ixodes ricinus.
- Treatment of infestations caused by ear mites (Otodectes cynotis).
Cestodes
- Treatment of infections caused by tapeworms (Dipylidium caninum, Taenia taeniaeformis, Echinococcus multilocularis, Joyeuxiella pasqualei, and Joyeuxiella fuhrmanni).
Nematodes
- Prevention of the disease caused by roundworms (Dirofilaria immitis) for one month
- Treatment of infections with gastrointestinal nematodes (L3, L4 larvae and adults of Toxocara cati, larvae and adults of Ancylostoma tubaeforme Ancylostoma ceylanicum and Toxascaris leonine and Цтсндщыещьф икфяшдшутыу-s zrdasruli formebi).
- Treatment of lungworm (L4 Troglostrongylus brevior larvae and adults) infections in cats.
Treatment of infections with vesical worms (capillaria plica).
Contraindications:
Do not use in case of hypersensitivity to the active substances or any of the excipients.
Adverse reactions:
Hypersalivation. Diarrhea, transient skin reactions at the application site (alopecia, pruritus), anorexia, lethargy and emesis were rarely observed in clinical trials shortly after application. This reaction is generally mild, short-lived and self-limiting.
The frequency of adverse reactions is determined as follows:
- Very common (an adverse reaction occurs in more than 1 in 10 animals during treatment)
- Common (more than 1 in 100 animals, but less than 10)
- Uncommon (more than 1 in 1,000 animals, but less than 10)
- Rare (more than 1 in 10,000 animals, but less than 10)
- Very rare (less than 1 in 10,000 animals, including isolated reports)
If you notice any side effects, including those not listed in this leaflet or if you think that the drug is not working, please inform your veterinarian.
Dosage:
The recommended minimum dose is 1.44 mg esafoxolaner, 0.48 mg eprinomectin and 10 mg praziquantel per kg of body weight.
